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Background
There are no acute treatments specifically for intracer-
ebral hemorrhage (ICH), but they are being sought in
randomized controlled trials. The treatment effect sizes
in ongoing and future trials are likely to be small, neces-
sitating large sample sizes.
Methods
We searched online trial registries for randomized con-
trolled trials investigating an acute treatment for ICH. For
the trials whose eligibility criteria could be assessed in a
prospective, community-based ICH cohort study (2010-11),
we quantified the proportions of patients who were eligible
and investigated influences on these proportions.
Results
We applied the eligibility criteria of 17 trials to 166 adults
with ICH, of whom between 0.6% (95% confidence inter-
val [CI] 0.1-3.3) to 40% (95% CI 33-48) were eligible for
each trial. Fewer patients were eligible for trials restricted
to patients randomized within 12 hours of ICH onset
compared to trials with a longer time window (p=0.03).
Each additional eligibility criterion reduced the portion
of eligible patients by 1.3% (95% CI 0.4-2.2; adjusted R2 =
0.47; p=0.004). At least 66% (95% CI 58-73) of the entire
cohort was ineligible for all of the six trials that were
ongoing at the time of this study.
Conclusion
Fewer than half of patients with ICH are eligible for cur-
rent randomized controlled trials. Future trials could
maximize enrollment by extending the time window after
ICH onset for recruitment and minimizing the number
of eligibility criteria. We are developing an online trial
eligibility simulator based on our dataset to assist investi-
gators planning future trials of treatments for ICH.
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